Contract analysis

SCHEDULE OF INVESTORS Exhibit A to the Series Seed Preferred Stock Purchase Agreement dated as of February 9, 2026 by and among Meridian Diagnostics, Inc. a Delaware corporation (the "Company") and the Investors listed herein This Schedule of Investors (this "Schedule") is attached to and forms an integral part of the Series Seed Preferred Stock Purchase Agreement dated as of February 9, 2026 (the "Agreement"), by an